Cargando…
The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism
BACKGROUND: Atherogenic dyslipoproteinemia is one of the most important risk factor for atherosclerotic changes development. Hypothyroidism is one of the most common causes of secondary dyslipidemias which results from reduced LDL clearance and therefore raised levels of LDL and apoB. Association be...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210611/ https://www.ncbi.nlm.nih.gov/pubmed/25300222 http://dx.doi.org/10.1186/1476-511X-13-158 |
_version_ | 1782341410127609856 |
---|---|
author | Minarikova, Zuzana Gaspar, Ludovit Kruzliak, Peter Celecová, Zuzana Oravec, Stanislav |
author_facet | Minarikova, Zuzana Gaspar, Ludovit Kruzliak, Peter Celecová, Zuzana Oravec, Stanislav |
author_sort | Minarikova, Zuzana |
collection | PubMed |
description | BACKGROUND: Atherogenic dyslipoproteinemia is one of the most important risk factor for atherosclerotic changes development. Hypothyroidism is one of the most common causes of secondary dyslipidemias which results from reduced LDL clearance and therefore raised levels of LDL and apoB. Association between small dense LDL (sdLDL) presentation and thyroid status has been examinated using polyacrylamide gel electrophoresis for lipoprotein subfractions evaluation. METHODS: 40 patients with diagnosed autoimmune hypothyroidism and 30 patients with autoimmune hyperthyroidism were treated with thyroxine replacement or thyreo-suppressive treatment. In both groups lipid profiles, LDL subractions, apolipoproteins (apoA1, apoB), apoA1/apoB ratio and atherogenic index of plazma (AIP) were examined before treatment and in state of euthyreosis. RESULTS: Thyroxine replacement therapy significantly reduced levels of total cholesterol (TC), LDL, triglycerides (TG) and also decreased levels of sdLDL (8,55±11,671 vs 0,83±1,693mg/dl; p<0,001), apoB and AIP. For estimation of atherogenic lipoprotein profile existence an AIP evaluation seems to be better than apoB measurement because of the more evident relationship with sdLDL (r=0,538; p<0,01). Thyreo-suppressive therapy significantly increased levels of TC, LDL, TG and apoB. The sdLDL was not found in hyperthyroid patients. CONCLUSIONS: Atherogenic lipoprotein profile was present in 52.5% of hypothyroid subjects, which is higher prevalence than in normal, age-related population. Substitution treatment leads to an improvement of the lipid levels, TG, apoB, AIP and LDL subclasses. It significantly changed the presentation of sdLDL – we noticed shift to large, less atherogenic LDL particles. Significantly positive correlation between sdLDL and TAG; sdLDL and VLDL alerts to hypertriglyceridemia as a major cardiovascular risk factor. |
format | Online Article Text |
id | pubmed-4210611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42106112014-10-29 The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism Minarikova, Zuzana Gaspar, Ludovit Kruzliak, Peter Celecová, Zuzana Oravec, Stanislav Lipids Health Dis Research BACKGROUND: Atherogenic dyslipoproteinemia is one of the most important risk factor for atherosclerotic changes development. Hypothyroidism is one of the most common causes of secondary dyslipidemias which results from reduced LDL clearance and therefore raised levels of LDL and apoB. Association between small dense LDL (sdLDL) presentation and thyroid status has been examinated using polyacrylamide gel electrophoresis for lipoprotein subfractions evaluation. METHODS: 40 patients with diagnosed autoimmune hypothyroidism and 30 patients with autoimmune hyperthyroidism were treated with thyroxine replacement or thyreo-suppressive treatment. In both groups lipid profiles, LDL subractions, apolipoproteins (apoA1, apoB), apoA1/apoB ratio and atherogenic index of plazma (AIP) were examined before treatment and in state of euthyreosis. RESULTS: Thyroxine replacement therapy significantly reduced levels of total cholesterol (TC), LDL, triglycerides (TG) and also decreased levels of sdLDL (8,55±11,671 vs 0,83±1,693mg/dl; p<0,001), apoB and AIP. For estimation of atherogenic lipoprotein profile existence an AIP evaluation seems to be better than apoB measurement because of the more evident relationship with sdLDL (r=0,538; p<0,01). Thyreo-suppressive therapy significantly increased levels of TC, LDL, TG and apoB. The sdLDL was not found in hyperthyroid patients. CONCLUSIONS: Atherogenic lipoprotein profile was present in 52.5% of hypothyroid subjects, which is higher prevalence than in normal, age-related population. Substitution treatment leads to an improvement of the lipid levels, TG, apoB, AIP and LDL subclasses. It significantly changed the presentation of sdLDL – we noticed shift to large, less atherogenic LDL particles. Significantly positive correlation between sdLDL and TAG; sdLDL and VLDL alerts to hypertriglyceridemia as a major cardiovascular risk factor. BioMed Central 2014-10-10 /pmc/articles/PMC4210611/ /pubmed/25300222 http://dx.doi.org/10.1186/1476-511X-13-158 Text en © Minarikova et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Minarikova, Zuzana Gaspar, Ludovit Kruzliak, Peter Celecová, Zuzana Oravec, Stanislav The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism |
title | The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism |
title_full | The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism |
title_fullStr | The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism |
title_full_unstemmed | The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism |
title_short | The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism |
title_sort | effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210611/ https://www.ncbi.nlm.nih.gov/pubmed/25300222 http://dx.doi.org/10.1186/1476-511X-13-158 |
work_keys_str_mv | AT minarikovazuzana theeffectsoftreatmentonlipoproteinsubfractionsevaluatedbypolyacrylamidegelelectrophoresisinpatientswithautoimmunehypothyroidismandhyperthyroidism AT gasparludovit theeffectsoftreatmentonlipoproteinsubfractionsevaluatedbypolyacrylamidegelelectrophoresisinpatientswithautoimmunehypothyroidismandhyperthyroidism AT kruzliakpeter theeffectsoftreatmentonlipoproteinsubfractionsevaluatedbypolyacrylamidegelelectrophoresisinpatientswithautoimmunehypothyroidismandhyperthyroidism AT celecovazuzana theeffectsoftreatmentonlipoproteinsubfractionsevaluatedbypolyacrylamidegelelectrophoresisinpatientswithautoimmunehypothyroidismandhyperthyroidism AT oravecstanislav theeffectsoftreatmentonlipoproteinsubfractionsevaluatedbypolyacrylamidegelelectrophoresisinpatientswithautoimmunehypothyroidismandhyperthyroidism AT minarikovazuzana effectsoftreatmentonlipoproteinsubfractionsevaluatedbypolyacrylamidegelelectrophoresisinpatientswithautoimmunehypothyroidismandhyperthyroidism AT gasparludovit effectsoftreatmentonlipoproteinsubfractionsevaluatedbypolyacrylamidegelelectrophoresisinpatientswithautoimmunehypothyroidismandhyperthyroidism AT kruzliakpeter effectsoftreatmentonlipoproteinsubfractionsevaluatedbypolyacrylamidegelelectrophoresisinpatientswithautoimmunehypothyroidismandhyperthyroidism AT celecovazuzana effectsoftreatmentonlipoproteinsubfractionsevaluatedbypolyacrylamidegelelectrophoresisinpatientswithautoimmunehypothyroidismandhyperthyroidism AT oravecstanislav effectsoftreatmentonlipoproteinsubfractionsevaluatedbypolyacrylamidegelelectrophoresisinpatientswithautoimmunehypothyroidismandhyperthyroidism |